OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic effect of uridine phosphorylase 1 (UPP1) inhibitor on liver fibrosis in vitro and in vivo
Elisa Feller Gonçalves da Silva, Bruna Pasqualotto Costa, Marcella Tornquist Nassr, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173670-173670
Open Access | Times Cited: 14

Showing 14 citing articles:

Uridine Alleviates Sepsis-Induced Acute Lung Injury by Inhibiting Ferroptosis of Macrophage
Kai Lai, Congkuan Song, Minglang Gao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5093-5093
Open Access | Times Cited: 54

Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis
Panu K. Luukkonen, Ikki Sakuma, Rafael Calais Gaspar, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 35

Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases
Yueyuan Yang, Yahong Ye, Yingfeng Deng, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 8

Mass spectrometry imaging reveals spatial metabolic variation and the crucial role of uridine metabolism in liver injury caused by Schistosoma japonicum
Qingkai Xue, Xiangyu Zhou, Yuyan Wang, et al.
PLoS neglected tropical diseases (2025) Vol. 19, Iss. 2, pp. e0012854-e0012854
Open Access

Uridine Phosphorylase 1 as a Biomarker Associated with Glycolysis in Acute Lung Injury
Congkuan Song, Qingqing Li, Jinjin Zhang, et al.
Inflammation (2025)
Open Access

The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics
Aziz Eftekhari, Allahveirdy Arjmand, Ayyub Asheghvatan, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 28

Ginsenoside-Rg1 acts as an IDO1 inhibitor, protects against liver fibrosis via alleviating IDO1-mediated the inhibition of DCs maturation
Chan Mo, Shuwen Xie, Ting Zeng, et al.
Phytomedicine (2021) Vol. 84, pp. 153524-153524
Closed Access | Times Cited: 24

Synthesis, Detection, and Metabolism of Pyridone Ribosides, Products of NAD Overoxidation
Faisal Hayat, J. Trey Deason, Ru Liu Bryan, et al.
Chemical Research in Toxicology (2024) Vol. 37, Iss. 2, pp. 248-258
Open Access | Times Cited: 1

The predictive value of plasma uridine for type 2 diabetes and its atherosclerotic complications
Yueyuan Yang, Tingting Yu, Zhili Niu, et al.
Endocrine Connections (2024) Vol. 13, Iss. 6
Open Access

Uridine Phosphorylase-1 supports metastasis of mammary cancer by altering immune and extracellular matrix landscapes of the lung
Declan Whyte, Johan Vande Voorde, David Sumpton, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

CPBMF65, an inhibitor of uridine phosphorylase 1, suppresses psoriasiform dermatitis in mice: a potential therapeutic approach for psoriasis
Fanfan Zeng, Pengcheng Cai, Yanqiu Yu, et al.
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access

Patent Highlights December 2021–January 2022
Hermann AM Mucke
Pharmaceutical Patent Analyst (2022) Vol. 11, Iss. 3, pp. 89-96
Closed Access

Page 1

Scroll to top